Previous work has shown that the anti-EGFR mAb cetuximab induces immunogenic cell death (ICD) in colon cancer cells by triggering endoplasmic reticulum stress response and CRT translocation, depending on the mutational status of the EGFR signaling pathway (36). The gene discussed is CALR; the disease is malignant colon neoplasm.